Brandywine Global Investment Management, LLC Albireo Pharma, Inc. Transaction History

Brandywine Global Investment Management, LLC

  • $14.2 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
SELL
$16.32 - $26.37 $26,634 - $43,035
-1,632 Reduced 3.73%
42,168 $816,000
Q2 2022

Aug 11, 2022
SELL
$18.54 - $37.29 $120,510 - $242,385
-6,500 Reduced 12.92%
43,800 $870,000
Q4 2021

Feb 11, 2022
BUY
$21.19 - $31.29 $1.07 Million - $1.57 Million
50,300 New
50,300 $1.17 Million

Others Institutions Holding ALBO

# of Institutions
4
Shares Held
865
Call Options Held
0
Put Options Held
0
View Full List

About ALBIREO PHARMA, INC.

ALBO Quotes by TradingView
  • Ticker ALBO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 19,612,500
  • Description
  • Albireo Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. The company offers Bylvay for the treatment of progressive familial intrahepatic cholestasis, as we...
More about ALBO
Track This Portfolio

Track Brandywine Global Investment Management, LLC Portfolio

Follow Brandywine Global Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brandywine Global Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Brandywine Global Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email